Updated Jul 16, 2026
PARSHALL B LYNNE has filed 4 SEC Form 4 filings across 3 companies in the last 90 days — selling. Lifetime open-market sales: $3.06M.

B Lynne Parshall is a corporate executive known for her role as a director at Cytokinetics Inc and other biopharmaceutical companies. She has extensive experience in the industry, particularly in corporate governance and strategic development.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-01 | CYTK | CYTOKINETICS INC | S — Open-market sale | 5.0K | $74.08 | $370K |
| 2026-05-27 | CYTK | CYTOKINETICS INC | A — Grant or award | 2.9K | $0.00 | |
| 2026-04-17 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale | 534 | $76.97 | $41K |
| 2026-04-17 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale | 4.5K | $76.19 | $340K |
| 2026-03-02 | CYTK | CYTOKINETICS INC | S — Open-market sale | 5.0K | $61.21 | $306K |
| 2026-02-14 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 5.0K | $82.72 | $414K |
| 2025-10-15 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale | 5.0K | $71.74 | $359K |
| 2025-09-02 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale | 9.2K | $51.49 | $476K |
| 2025-09-02 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale | 10.8K | $50.42 | $542K |
| 2025-08-06 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale | 400 | $42.63 | $17K |
| 2025-08-06 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale | 4.6K | $41.87 | $193K |
| 2025-07-15 | IONS | IONIS PHARMACEUTICALS INC | M — Option exercise | 4.1K | $0.00 | |
| 2025-05-14 | CYTK | CYTOKINETICS INC | A — Grant or award | 7.3K | $0.00 |
B Lynne Parshall is a corporate executive known for her role as a director at Cytokinetics Inc and other biopharmaceutical companies. She has extensive experience in the industry, particularly in corporate governance and strategic development.…
4 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 0 open-market purchases () and 10 open-market sales ($3.06M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live PARSHALL B LYNNE profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.